Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis

Journal of the American College of Cardiology

Volumn 35, Issue 6, 2000, Pages 1535-1542

  Heeschen, Christopher ^a   Hamm, Christian W ^b   Bruemmer, Jens ^c   Simoons, Maarten L ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KERCKHOFF HEART CENTER   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANTIBODIES, MONOCLONAL; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; RECURRENCE; SURVIVAL RATE; TROPONIN T;

EID: 0034111390     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00581-7     Document Type: Article

References (34)

1. Farb A., Burke A.P., Tang A.L., et al. Coronary plaque erosion without rupture into a lipid core. Circulation. 93:1996;1354-1363.
2. Davies M.J. The composition of coronary-artery plaques. N Engl J Med. 336:1997;1312-1313.
3. Falk E. Unstable angina with fatal outcome dynamic coronary thrombosis leading to infarction and/or sudden mortality: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion . Circulation. 711:1985;699-708.
4. Davies M.J., Thomas A.C., Knapman P.A., Hangartner J.R. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac mortality. Circulation. 73:1986;418-427.
5. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 327:1992;146-150.
6. Hamm C.W., Goldmann B.U., Heeschen C., et al. Emergency room triage of patients with acute chest pain based on rapid testing for troponin T or troponin I. N Engl J Med. 337:1997;1648-1653.
7. Lindahl B., Andren B., Ohlsson J., et al. Noninvasive risk stratification in unstable coronary artery disease exercise test and biochemical markers . Am J Cardiol. 80:(5A):1997;40E-44E.
8. Lüscher M.S., Thygesen K., Ravkilde J., Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary disease. Circulation. 96:1997;2578-2585.
9. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 335:1996;1333-1341.
10. Pettijohn T.L., Doyle T., Spiekerman A.M., et al. Usefulness of positive troponin-T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris. Am J Cardiol. 80:1997;510-511.
11. Ravkilde J., Nissen H., Horder M., Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. J Am Coll Cardiol. 25:1995;574-581.
12. Wu A.H., Abbas S.A., Green S., et al. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol. 76:1995;970-972.
13. Hamm C.W., Heeschen C., Goldmann B.U., et al. Troponin T predicts the benefit of abciximab in patients with unstable angina in the CAPTURE study. N Engl J Med. 340:1999;1623-1629.
14. Anderson J.L., Carlquist J.F., Muhlestein J.B., et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 32:1998;35-41.
15. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
16. Haverkate F., Thompson S.G., Pyke S.D., et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466.
17. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
18. Benamer H., Steg P.G., Benessiano J., et al. Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris. Am J Cardiol. 82:1998;845-850.
19. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes a TIMI 11A substudy . J Am Coll Cardiol. 31:1998;1460-1465.
20. Toss H., Lindahl B., Siegnahm A., Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary heart disease. Circulation. 96:1997;4204-4210.
21. Curzen N.P., Patel D.J., Kemp M., et al. Can C-reactive protein or troponin T and I predict outcome in patients with intractable unstable angina? Heart. 80:1998;23-27.
22. Rebuzzi A.G., Quaranta G., Liuzzo G., et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol. 82:1998;715-719.
23. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina the CAPTURE study . Lancet. 349:1997;1429-1435.
24. Katus H.A., Looser S., Hallermayer K., et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 38:1992;386-393.
25. Katus H.A., Remppis A., Neumann F.J., et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
26. Ledue T.B., Weiner D.L., Sipe J.D., et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 35:1998;745-753.
27. Harrel F.E., Lee K.L., Polloch B.G. Regression models in clinical studies determining relationships between predictors and response . Natl Cancer Inst. 80:1988;1198-1202.
28. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;John Wiley & Sons, New York.
29. Heeschen C., van den Brand M., Hamm C.W., Simoons M.L. Angiographic findings according to TnT. Circulation. 100:1999;1509-1514.
30. Benamer H., Steg P.G., Benessiano J., et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J. 137:1999;815-820.
31. Lincoff A.M., Tcheng J.E., Califf R.M., et al. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab. Circulation. 99:1999;1951-1958.
32. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696.
33. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
34. Ridker P.M., Rifai N., Pfeffer M.A., et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 100:1999;230-235.